DIPIVEFRIN HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dipivefrin Hydrochloride, and when can generic versions of Dipivefrin Hydrochloride launch?
Dipivefrin Hydrochloride is a drug marketed by Bausch And Lomb and Falcon Pharms and is included in two NDAs.
The generic ingredient in DIPIVEFRIN HYDROCHLORIDE is dipivefrin hydrochloride. There are five drug master file entries for this compound. Additional details are available on the dipivefrin hydrochloride profile page.
US Patents and Regulatory Information for DIPIVEFRIN HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | DIPIVEFRIN HYDROCHLORIDE | dipivefrin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 074188-001 | May 19, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Falcon Pharms | DIPIVEFRIN HYDROCHLORIDE | dipivefrin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 073636-001 | Jun 30, 1994 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
